Vertigo relief app

📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.

TL;DR

A new digital app for vertigo relief is being developed to assist adults with BPPV in performing repositioning maneuvers at home. It targets patients and clinics, with validation plans underway. The app aims to improve self-treatment and reduce relapse rates.

A new vertigo relief app is in development to assist adults suffering from benign paroxysmal positional vertigo (BPPV) in performing repositioning maneuvers at home. The app aims to address long-standing gaps in self-treatment and is targeted for potential recommendation by ENT clinics, audiologists, and vestibular physiotherapists. The Question No To-Do App Can Answer This initiative responds to increased demand for remote management options in vestibular disorders, especially in the context of shifting healthcare delivery models.

The app is designed as a mobile platform compatible with iOS and Android devices. Its core features include screening users for BPPV candidacy through a short safety survey and optional motion-sensor self-checks, guiding users step-by-step through maneuvers like the Epley and Brandt-Daroff with animated visuals, audio cues, and gyroscope-based head-angle feedback. Additionally, it will log dizziness episodes, triggers, and severity over time to help users track their condition.

Developers plan to launch a freemium model, offering basic maneuver guides free of charge, with paid options for advanced symptom tracking, history export, and reminders. They also aim to commercialize the app through a B2B model, licensing it to ENT, audiology, and physiotherapy clinics for patient home care programs. They also aim to commercialize the app through a B2B model, licensing it to ENT, audiology, and physiotherapy clinics for patient home care programs. Validation efforts include building a landing page, running targeted ads for vertigo/BPPV searches, and measuring signups and engagement, alongside pitching clinics for trial partnerships. Guest app with day-of seating lookup and schedule

Potential Impact on Self-Management of Vertigo

This app could significantly improve self-treatment for BPPV, a common vestibular disorder affecting many adults, especially women and older individuals. By providing guided, accurate repositioning at home, it may reduce reliance on long wait times for specialist care and decrease recurrence rates, which occur in roughly half of cases. If adopted widely, it could also streamline clinical workflows by enabling clinicians to recommend a validated digital tool for ongoing patient support, potentially lowering healthcare costs and improving quality of life for sufferers.

Rising Demand for Digital Vestibular Solutions

Benign paroxysmal positional vertigo (BPPV) is the most common vestibular disorder, often causing brief episodes of dizziness triggered by head movements. Traditionally, treatment involves manual repositioning maneuvers performed in clinics, but many patients struggle to execute these correctly at home. The COVID-19 pandemic accelerated a shift toward telehealth and remote rehabilitation, with smartphones now equipped with sensors capable of measuring head angles accurately. The digital therapeutics market for vestibular disorders was valued near USD 498 million in 2024, with a projected compound annual growth rate of approximately 13.5% through 2033, reflecting increasing acceptance among providers and payers.

“The app aims to bridge the gap between clinical visits and home management by providing real-time guidance and tracking for patients.”

— an anonymous researcher

Validation and Adoption Challenges Remain

It is not yet confirmed how effectively the app will perform in real-world settings or whether patients will adopt it widely. Validation plans are still in development, including pilot testing with clinics and user engagement metrics. The extent to which ENT and other specialists will recommend or white-label the app remains uncertain, as does its long-term impact on relapse rates and healthcare costs.

Upcoming Validation and Pilot Testing Phases

Developers plan to launch a landing page and run targeted advertising campaigns to gauge interest and measure engagement. Concurrently, they will approach 10-15 ENT, audiology, and physiotherapy clinics to pilot the app with patients, collecting feedback on usability and clinical utility. These steps aim to validate the app’s effectiveness and inform future regulatory and commercial strategies.

Key Questions

When will the vertigo relief app be available for download?

The app is currently in development, with validation and pilot testing phases underway. A public release date has not yet been announced.

Will the app replace visits to ENT specialists?

No. The app is designed as a self-management tool to complement clinical care, not substitute professional diagnosis or treatment. It will include disclaimers advising users to consult healthcare providers for red-flag symptoms.

Can the app be used by anyone with vertigo?

The initial focus is on adults with recurrent positional vertigo or BPPV. Users will undergo a screening process to determine candidacy before guided maneuvers are recommended.

Will clinics be able to customize or white-label the app?

Yes, the developers plan to offer a licensing model for clinics, allowing them to integrate the app into their patient care programs as a white-label solution.

What features will the app include?

Key features include screening tools, animated step-by-step maneuver guides with audio cues, gyroscope-based feedback, symptom logging, and progress tracking over time.

Source: IdeaNavigator AI